Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Multicenter study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and
pharmacodynamics (PD) of BION-1301 in healthy volunteers and adults with IgA Nephropathy
(IgAN).